“Final Report will add the analysis of the impact of COVID-19 on industry.”
Report Ocean has recently published a comprehensive study on the India Generic Drugs Market, covering the prediction period of 2023-2031. Throughout the years, this report has diligently examined the industry, taking into account various factors such as macroeconomic parameters, consumer buying patterns, microeconomic parameters, GDP growth rate, inflation rate, and market demand-supply scenarios.
market players, such as [Teva Pharmaceutical Industries, Wockhardt Pharmaceutical, and Sandoz – A Novartis division. Other major players in India generic drugs market are Fresenius Kabi, Aurobindo Pharma, Sun Pharma, Dr.Reddys Laboratories, Lupin, Cipla, and Viatris
Russia-Ukraine War on Market
The market is anticipated to suffer because of the Russia-Ukraine War. The demand for the market has decreased as a result of the political unrest and economic unrest in the area. The war had a detrimental impact on global economic activity, adding to inflationary pressures globally and hindering the post-pandemic recovery, even if it was not the primary cause of the slower-than-anticipated economic growth in 2022 and revised estimates for 2023.
Download Free Sample of This Strategic Report:https://reportocean.com/industry-verticals/sample-request?report_id=MR436
The healthcare sector is vital to both national economies and people all across the world. One of the industries with the fastest growth rates is this one. There is a correlation between income levels and healthcare spending across nations because healthcare spending accounts for more than 10% of the GDP of the majority of developed countries. According to the Centers for Medicare and Medicaid Services, US healthcare spending increased by 4.6% in 2019 to reach US$ 3.8 trillion, or US$ 11,582 per person and represented 17.7% of GDP. Additionally, households paid for 28.4% of all health expenditures, followed by the federal government for 29.0%. 16.1% of all healthcare costs were paid for by state and municipal governments, while 7.5% came from other private sources.
India Generic Drugs Market to Grow at 11% during 2022 2028
India generic drugs market is being driven by several factors, including the expanding pharmaceutical industry of India, implementation of favorable initiatives from the government, increasing foreign investment, and rising healthcare expenditure in the country
A study, recently conducted by the strategic consulting and market research firmReport Ocean, revealed that India generic drugs market is projected to grow at a CAGR of 11.3% during the forecast period (2022-2028).India generic drugs market is being driven by several factors, including the thriving pharmaceutical industry of India, increasing government initiatives, increasing foreign investment, and rising healthcare expenditures in the country. Moreover, the growing number of health issues and rising health awareness have also created a growing demand for generic drugs in India.
Favorable government initiatives driving the growth of India generic drugs market
Support from the government is essential for the growth of any market in any country. Currently, the Indian government is promoting its “Make in India” policy and encouraging investment in the pharmaceutical industry to make India a global hub and leader in the sector. For instance, the government has launched Production Linked Incentive (PLI) Scheme with a scheme outlay worth USD 2.9 billion. Several other schemes, such as Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS), Pharmaceutical Promotion & Development Scheme (PPDS), and others are also playing a key role in powering India generic drugs market. Additionally, the government allows 100% foreign investment in the pharmaceutical industry, which has helped the country in attracting significant foreign investment. Hence, several initiatives from the government are supporting the growth of India generic drugs market.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=MR436
Injectable route of administration to register higher CAGR in India Generic Drugs Market
Based on the route of administration, India generic drugs market is bifurcated into topical, oral, injectable, and others. During the forecast period, the injectable segment is expected to register the highest growth rate owing to the quick action of injectable drugs and their minimal side effects. Oral and topical drugs require time to work and may cause side effects. In addition, injectable drugs are preferred for severe diseases and health conditions, contributing to the segment’s high growth rate.
Impact of COVID-19
There was an explosion in demand for generic medicines in India in 2020 and 2021 as the COVID-19 pandemic swept the country and the world. According to the Ministry of Commerce and Industry, Drug formulations & Biologicals registered an 11.27% increase in FY 2019-2020 from the year before. In FY2022-21, pharmaceutical exports rose 18.07% and reached USD 24.44 billion as per the Pharmaceuticals Export Promotion Council of India (Pharmexcil). Amid the recent emergence of the Omicron variant of the coronavirus, the demand for generic drugs has gone up once again with Dolo 650 and Dolo 500 registering exponential demand. The generic drug market in India is expected to grow strongly in the coming years due to government support and growing demand from both domestic and international markets.
Market Segment:
By Product Type(Simple Generics, Super Generics, And Biosimilars)
By Route Of Administration(Oral, Topical, Injectable, And Others)
By Application(Cardiovascular Products, Anti-Infective Drugs, Central Nervous System Drugs, Anti-Cancer Drugs, Respiratory Products, And Others)
By Distribution Channel(Hospitals/Clinics, Retail Pharmacies, And Online Pharmacies)
India’s generic drugs market is a fragmented market with several major players operating within it. The new companies are battling with established players to gain a significant share of the market. Collaboration, merger & acquisitions, partnerships, and launch of new projects are some of the strategies adopted by the players operating in India generic drugs market to gain an advantage over their competitors.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=MR436
Recent Development
In December 2021, Sun Pharmaceuticals announced that it is planning to set up a new manufacturing facility in Andhra Pradesh. Founder of the company, Dilip Shanghvi met Chief Minister of Andra Pradesh YS Jagan Mohan Reddy to discuss the set-up of the plant. Sun Pharmaceuticals is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over USD 4.5 billion. Additionally, it is supported by more than 40 manufacturing facilities. The company supplies its drugs to more than 100 countries around the globe.
In October 2021, AbbVie, the U.S. drug manufacturer which sells the world’s top selling drug, Humira, announced that it is planning to launch products in India by the end of 2023 or 2024 from its global portfolio. The company is looking to tap the potential of Indian market for unmet medical needs against diseases such as leukaemia, psoriasis, eczema and Alzheimer’s. The company is also considering making India part of its phase-3 trials for potential therapies under development.
Table of Content:
- Report Overview
- Global Growth Trends
- Competition Landscape by Key Players
- Data Segments
- North America Market Analysis
- Europe Market Analysis
- Asia-Pacific Market Analysis
- Latin America Market Analysis
- Middle East & Africa Market Analysis
- Key Players Profiles Market Analysis
- Analysts Viewpoints/Conclusions
- Appendix
Reasons to Buy:
Informed decision-making: Market research reports provide valuable insights into industry trends, customer behavior, and competitor analysis. This information can help businesses make informed decisions about product development, pricing, and marketing strategies.
Competitive advantage: By identifying market gaps and opportunities, market research reports can provide a competitive advantage that can help businesses differentiate themselves from their competitors and gain a larger share of the market.
Industry expertise: Market research reports are prepared by industry experts who have a deep understanding of the market and its dynamics. These reports provide an unbiased and objective view of the industry, which can be invaluable for businesses that want to gain a deeper understanding of the market.
Saves time and money: Conducting market research can be time-consuming and expensive. By purchasing a market research report, businesses can save time and money by accessing a comprehensive and detailed analysis of the market.Risk management : Market research reports can help businesses manage risks associated with market entry, product development, and expansion. By providing a detailed analysis of the market and its trends, businesses can make informed decisions that minimize risks and maximize returns.
Request full Report– https://reportocean.com/industry-verticals/sample-request?report_id=MR436
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Report Ocean:
Email:sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel:+1 888 212 3539 (US – TOLL FREE)
Website:https://www.reportocean.com